Parkinson's disease

Parkinson's disease (PD) is a neurodegenerative disorder characterized by progressive loss of neurons in the substantia nigra, leading to dopamine deficiency and motor impairment. The main clinical characteristics of the disease include rigidity, bradykinesia, resting tremor, and postural instability. PD usually begins in middle age, but begins later in life in a significant proportion of patients. The disease is progressive and can have a significant impact on the patient's quality of life and that of others, requiring a comprehensive approach to therapy and rehabilitation.

History of the disease and interesting historical facts

Parkinson's disease was first described in 1817 by the English physician James Parkinson in his work "An Essay on the Shaking Palsy." The disease was later named after him. In the first half of the 20th century, scientists identified some of the neurobiological mechanisms that determine the pathogenesis of this disorder. In the 1960s, significant progress was made in understanding the role of dopamine, which contributed to the development of effective pharmacological treatments. In addition, cases of familial predisposition were described, which made it possible to study the genetic aspects of the disease. The history of Parkinson's disease also includes many interesting cases associated with famous historical figures such as Mohandas Gandhi and the composer Igor Stravinsky, which highlights the diversity of manifestations of the disease even among highly gifted people.

Epidemiology

Epidemiological studies show that Parkinson's disease affects about 1-2% of the population over 60 years of age, with an increasing prevalence of 4-5% in older age groups. The overall incidence of neurodegenerative disorders varies from region to region. According to the World Health Organization, the number of patients with PD in the world in 2020 was estimated at 8.5 million. There is also a gender difference in prevalence: men suffer from this disease 1.5-2 times more often than women. In terms of age, based on statistics, the average age of onset of the disease is 60-65 years.

Genetic predisposition to this disease

Genetic studies have identified several genes associated with Parkinson's disease. The most significant are SNCA, LRRK2, PARK7, PINK1, and PRKN. Mutations in these genes can lead to early onset of the disease, as well as less predictable forms of its progression. For example, mutations in the LRRK2 gene are considered the most common cause of the inherited form of PD. Genetic factors can both increase the risk of the disease and have a protective effect; for example, certain variants of the GBA gene are associated with an increased risk of developing the disease. It is important to note that although genetic predisposition plays a role, the environment and other factors also influence an individual's risk.

Risk factors for the development of this disease

There are numerous risk factors that may contribute to the development of Parkinson's disease. These include:

• Age - the risk of disease increases significantly with increasing age.
• Gender - Men have a much higher risk of developing PD than women.
• Environmental factors – exposure to certain toxic substances such as pesticides and heavy metals.
• Brain injury - previous injuries may increase the risk of developing the disease.
• Certain medical conditions, such as hypertension and diabetes, can contribute to the development of PD.
• Heredity - having relatives with the disease increases the likelihood of its manifestation.

Each of these factors can contribute to an increased likelihood, but the mere presence of a risk factor does not guarantee the development of the disease.

Diagnosis of this disease

The diagnosis of Parkinson's disease is based on clinical evaluation, as laboratory tests and radiological studies are not specific. The main symptoms include:

• Tremor at rest.
• Rigidity (increased muscle tone).
• BradyCINES (slowness of movement).
• Impaired balance and coordination.

Laboratory tests can be used to rule out other diseases, but do not indicate Parkinson's disease. Neuroimaging, such as MRI or PET, can help in this process by visualizing changes in brain structures. It is also important to conduct differential diagnosis with other disorders, such as thyroid disease, cerebrovascular disease, muscle atrophy, and others.

Treatment

Treatment of Parkinson's disease can be multifaceted, including both pharmacological and non-surgical methods. Pharmacological treatment is aimed at managing symptoms and is based on the use of levodopa, which is converted into dopamine, improving the condition of patients. In addition, drugs such as bodipinar (bromocriptine) and dopamine agonists are used. In later stages of the disease, surgical treatment may be considered, for example, deep brain stimulation, which can significantly improve the quality of life. Non-surgical methods include physiotherapy, occupational therapy and speech therapy to improve function and adaptation. It is important to consider the individual needs of each patient and regularly review the treatment plan.

List of medications used to treat this disease

The main drugs used to treat Parkinson's disease include:

• Levodopa/carbidopa (Sinemet).
• Dopamine agonists (eg pramipexole, ropinirole).
• MAO-B inhibitors (selegiline).
• Anticholinergic drugs (trihexyphenidyl).
• Drugs to control mood disorders (antidepressants).

Each drug has its own indications and contraindications, and the choice of therapy should be based on the clinical picture and individual patient factors.

Disease monitoring

Disease monitoring involves regular assessments of the patient to detect changes in symptoms and adjust therapy accordingly. Follow-up visits should be performed at least every 6 to 12 months to assess quality of life and functional status. The prognosis of Parkinson's disease depends on a number of factors, including age of onset, overall health, and response to treatment. Complications of the disease may include motor and non-motor symptoms, such as sleep disorders and cognitive changes, which significantly affect quality of life.

Age-related features of the disease

The manifestations of Parkinson's disease can vary depending on the patient's age. In younger patients, symptoms can be more aggressive, often with the manifestation of early movement disorders and dependence on care. In older people, the disease progresses more slowly, but they are more likely to suffer from comorbidities, which can complicate treatment. Older patients are also more likely to have mental disorders.

Questions and Answers

• What is Parkinson's disease? Parkinson's disease is a neurodegenerative disorder characterized by progressive loss of dopaminergic neurons and the development of motor and non-motor symptoms.
• What are the main symptoms of Parkinson's disease? The main symptoms include resting tremor, rigidity, bradykinesia and postural instability.
• How is the possibility of Parkinson's disease diagnosed? Diagnosis is primarily based on clinical symptoms, and neuroimaging and laboratory tests may be used to exclude other diseases.
• What treatments are used for Parkinson's disease? Treatment may include pharmacological therapy using levodopa, as well as physical rehabilitation and surgical techniques such as deep brain stimulation.
• What is the prognosis for Parkinson's disease? The prognosis depends on many factors, including age and overall health, but the disease is progressive and can significantly reduce quality of life.